Open sidebar
Focus
Bristol-Myers
Business & Markets
|
Reuters
Bristol Myers Boosts Cancer Drug Portfolio With $4.1 Billion Turning Point Deal
Jun 04, 2022
|
Reuters
Jun 04
|
Health News
|
Reuters
Bristol Myers Drug Wins First US Approval for Graft Versus Host Disease Prevention
Dec 15, 2021
|
Reuters
Dec 15
|